September 2020
Using Anticoagulants to Treat Patients With Obesity Presents Challenges
October 05, 2020
Article
Health-System Edition
Leaders in the field provide an overview of the DOAC drug class and how best to use the growing number of options.
Many Platforms Offer Rapid Detection in Bloodstream Infections
October 02, 2020
Article
Health-System Edition
Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.
Plethora of Clinical Trials Explore Gastric Cancer Treatments
October 01, 2020
Article
Health-System Edition
Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.
Anticoagulants, Antiretrovirals Can Prevent Strokes in AF for Patients With HIV
September 30, 2020
Article
Health-System Edition
Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.
Consider Real Costs Before Implementing a 340B Program
September 29, 2020
Article
Health-System Edition
Proposed CMS changes could hurt many health systems that are already struggling due to COVID-19 pandemic.
LTC Pharmacists Drive Positive Clinical Outcomes
September 28, 2020
Article
Health-System Edition
Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.
Patient Assistance Programs Are the Good, the Bad, and the Ugly
September 27, 2020
Article
Health-System Edition
Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.
Asembia offers a complete ecosystem of products and services focused on financial solutions and contracting programs to the specialty pharmacy market.
September 27, 2020
Article
Health-System Edition
Asembia is the industry’s leading group purchasing organization (GPO) focused on the specialty pharmacy market.
When Will a Vaccine Be Ready?
September 25, 2020
Article
Health-System Edition
As we head into flu season, count on Directions in Health-System Pharmacy™ to continue to report on the latest developments on COVID-19.